{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:30:20Z","timestamp":1760189420690},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T00:00:00Z","timestamp":1425859200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s12519-015-0009-3","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T10:46:07Z","timestamp":1425897967000},"page":"96-102","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effect of etanercept on refractory systemic-onset juvenile idiopathic arthritis"],"prefix":"10.1007","volume":"12","author":[{"given":"Xiao","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bi-Ru","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Liang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,9]]},"reference":[{"key":"9_CR1","volume-title":"Textbook of pediatric rheumatology","author":"JT Cassidy","year":"2005","unstructured":"Cassidy JT, Petty RE. Textbook of pediatric rheumatology, 5th ed. Philadelphia: Saunders, 2005.","edition":"5"},{"key":"9_CR2","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007;369:767\u2013778.","journal-title":"Lancet"},{"key":"9_CR3","first-page":"491","volume":"27","author":"C Lomater","year":"2000","unstructured":"Lomater C, Gerloni V, Gattinara M, Mazzotti J, Cimaz R, Fantini F. Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years. J Rheumatol 2000;27:491\u2013496.","journal-title":"J Rheumatol"},{"key":"9_CR4","first-page":"291","volume":"67","author":"P Kahn","year":"2009","unstructured":"Kahn P. Juvenile idiopathic arthritis\u2014current and future therapies. Bull NYU Hosp Jt Dis 2009;67:291\u2013302.","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"9_CR5","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/acr.21625","volume":"64","author":"EM DeWitt","year":"2012","unstructured":"DeWitt EM, Kimura Y, Beukelman T, Nigrovic PA, Onel K, Prahalad S, et al. Consensus treatment plans for newonset systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken) 2012;64:1001\u20131010.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"9_CR6","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/art.1780401019","volume":"40","author":"CA Wallace","year":"1997","unstructured":"Wallace CA, Sherry DD. Trial of intravenous pulse cyclophosphamide and methylprednisolone in the treatment of severe systemic-onset juvenile rheumatoid arthritis. Arthritis Rheum 1997;40:1852\u20131855.","journal-title":"Arthritis Rheum"},{"key":"9_CR7","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/rheumatology\/40.8.907","volume":"40","author":"V Gerloni","year":"2001","unstructured":"Gerloni V, Cimaz R, Gattinara M, Arnoldi C, Pontikaki I, Fantini F. Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10-year prospective study. Rheumatology (Oxford) 2001;40:907\u2013913.","journal-title":"Results of a 10-year prospective study. Rheumatology (Oxford)"},{"key":"9_CR8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s11926-000-0069-8","volume":"2","author":"NM Wulffraat","year":"2000","unstructured":"Wulffraat NM, Sanders LA, Kuis W. Autologous hemopoietic stem-cell transplantation for children with refractory autoimmune disease. Curr Rheumatol Rep 2000;2:316\u2013323.","journal-title":"Curr Rheumatol Rep"},{"key":"9_CR9","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/01.bor.0000169363.69066.d0","volume":"17","author":"A Adams","year":"2005","unstructured":"Adams A, Lehman TJ. Update on the pathogenesis and treatment of systemic onset juvenile rheumatoid arthritis. Curr Opin Rheumatol 2005;17:612\u2013616.","journal-title":"Curr Opin Rheumatol"},{"key":"9_CR10","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","volume":"48","author":"P Quartier","year":"2003","unstructured":"Quartier P, Taupin P, Bourdeaut F, Lemelle I, Pillet P, Bost M, et al. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. Arthritis Rheum 2003;48:1093\u20131101.","journal-title":"Arthritis Rheum"},{"key":"9_CR11","first-page":"545","volume":"23","author":"MM Katsicas","year":"2005","unstructured":"Katsicas MM, Russo RA. Use of infliximab in patients with systemic juvenile idiopathic arthritis refractory to etanercept. Clin Exp Rheumatol 2005;23:545\u2013548.","journal-title":"Clin Exp Rheumatol"},{"key":"9_CR12","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","volume":"201","author":"V Pascual","year":"2005","unstructured":"Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 2005;201:1479\u20131486.","journal-title":"J Exp Med"},{"key":"9_CR13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.2010.134254","volume":"70","author":"P Quartier","year":"2011","unstructured":"Quartier P, Allantaz F, Cimaz R, Pillet P, Messiaen C, Bardin C, et al. A multicentre, randomised, double-blind, placebocontrolled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial). Ann Rheum Dis 2011;70:747\u2013754.","journal-title":"Ann Rheum Dis"},{"key":"9_CR14","first-page":"2071","volume":"31","author":"JW Verbsky","year":"2004","unstructured":"Verbsky JW, White AJ. Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis. J Rheumatol 2004;31:2071\u20132075.","journal-title":"J Rheumatol"},{"key":"9_CR15","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1136\/ard.2003.014886","volume":"63","author":"G Horneff","year":"2004","unstructured":"Horneff G, Schmeling H, Biedermann T, Foeldvari I, Ganser G, Girschick HJ, et al. The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis 2004;63:1638\u20131644.","journal-title":"Ann Rheum Dis"},{"key":"9_CR16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3899\/jrheum.130690","volume":"41","author":"S Yokota","year":"2014","unstructured":"Yokota S, Imagawa T, Mori M, Miyamae T, Takei S, Iwata N, et al. Longterm safety and effectiveness of the anti-interleukin 6 receptor monoclonal antibody tocilizumab in patients with systemic juvenile idiopathic arthritis in Japan. J Rheumatol 2014;41:759\u2013767.","journal-title":"J Rheumatol"},{"key":"9_CR17","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","volume":"371","author":"S Yokota","year":"2008","unstructured":"Yokota S, Imagawa T, Mori M, Miyamae T, Aihara Y, Takei S, et al. Efficacy and safety of tocilizumab in patients with systemiconset juvenile idiopathic arthritis: a randomised, doubleblind, placebo-controlled, withdrawal phase III trial. Lancet 2008;371:998\u20131006.","journal-title":"Lancet"},{"key":"9_CR18","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","volume":"367","author":"F Benedetti De","year":"2012","unstructured":"De Benedetti F, Brunner HI, Ruperto N, Kenwright A, Wright S, Calvo I, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med 2012;367:2385\u20132395.","journal-title":"N Engl J Med"},{"key":"9_CR19","first-page":"2290","volume":"31","author":"CA Wallace","year":"2004","unstructured":"Wallace CA, Ruperto N, Giannini E, Childhood Arthritis and Rheumatology Research Alliance, Pediatric Rheumatology International Trials Organization, Pediatric Rheumatology Collaborative Study Group. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004;31:2290\u20132294.","journal-title":"J Rheumatol"},{"key":"9_CR20","first-page":"935","volume":"32","author":"Y Kimura","year":"2005","unstructured":"Kimura Y, Pinho P, Walco G, Higgins G, Hummell D, Szer I, et al. Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis. J Rheumatol 2005;32:935\u2013942.","journal-title":"J Rheumatol"},{"key":"9_CR21","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1002\/art.10444","volume":"46","author":"K Minden","year":"2002","unstructured":"Minden K, Niewerth M, Listing J, Biedermann T, Bollow M, Sch\u00f6ntube M, et al. Long-term outcome in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002;46:2392\u20132401.","journal-title":"Arthritis Rheum"},{"key":"9_CR22","first-page":"1989","volume":"29","author":"K Oen","year":"2002","unstructured":"Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Cheang M. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol 2002;29:1989\u20131999.","journal-title":"J Rheumatol"},{"key":"9_CR23","first-page":"401","volume":"30","author":"AV Ramanan","year":"2003","unstructured":"Ramanan AV, Schneider R. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis. J Rheumatol 2003;30:401\u2013403.","journal-title":"J Rheumatol"},{"key":"9_CR24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1517\/14740338.2014.899579","volume":"13","author":"G Murdaca","year":"2014","unstructured":"Murdaca G, Span\u00f2 F, Contatore M, Guastalla A, Magnani O, Puppo F. Efficacy and safety of etanercept in chronic immunemediated disease. Expert Opin Drug Saf 2014;13:649\u2013661.","journal-title":"Expert Opin Drug Saf"},{"key":"9_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14740338.2012.630388","volume":"11","author":"G Murdaca","year":"2012","unstructured":"Murdaca G, Colombo BM, Cagnati P, Gulli R, Span\u00f2 F, Puppo F. Update upon efficacy and safety of TNF-\u03b1 inhibitors. Expert Opin Drug Saf 2012;11:1\u20135.","journal-title":"Expert Opin Drug Saf"},{"key":"9_CR26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1517\/14740338.2013.755957","volume":"12","author":"G Murdaca","year":"2013","unstructured":"Murdaca G, Span\u00f2 F, Puppo F. Selective TNF-a inhibitorinduced injection site reactions. Expert Opin Drug Saf 2013;12:187\u2013193.","journal-title":"Expert Opin Drug Saf"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-015-0009-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12519-015-0009-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-015-0009-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T18:05:06Z","timestamp":1717783506000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12519-015-0009-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,9]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["9"],"URL":"https:\/\/doi.org\/10.1007\/s12519-015-0009-3","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,9]]}}}